当前位置:首页 - 行情中心 - 兴齐眼药(300573) - 财务分析 - 现金流量表

兴齐眼药

(300573)

  

流通市值:119.50亿  总市值:155.61亿
流通股本:2.74亿   总股本:3.57亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金676,557,246.862,439,399,907.521,833,095,200.261,140,671,875.59
  收到的税费返还-320,638.74--
  收到其他与经营活动有关的现金2,510,197.6417,867,206.2115,040,435.5215,100,925.11
  经营活动现金流入小计679,067,444.52,457,587,752.471,848,135,635.781,155,772,800.7
  购买商品、接受劳务支付的现金34,913,421.24186,411,330.45140,630,297.0689,201,779.43
  支付给职工以及为职工支付的现金173,870,649.16620,224,927.67467,601,331.97305,850,969.36
  支付的各项税费97,411,482.96309,204,408.82241,149,021.54166,090,711.89
  支付其他与经营活动有关的现金164,424,491.7588,358,299.85424,234,800.91289,079,458.44
  经营活动现金流出小计470,620,045.061,704,198,966.791,273,615,451.48850,222,919.12
  经营活动产生的现金流量净额208,447,399.44753,388,785.68574,520,184.3305,549,881.58
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额-50,00044,247.7944,247.79
  收到的其他与投资活动有关的现金-4,631,632.36--
  投资活动现金流入的平衡项目-000
  投资活动现金流入小计-4,681,632.3644,247.7944,247.79
  购建固定资产、无形资产和其他长期资产支付的现金26,637,575.12270,526,699.17131,875,957.5688,822,269.87
  支付其他与投资活动有关的现金400,0003,890,831.82--
  投资活动现金流出小计27,037,575.12274,417,530.99131,875,957.5688,822,269.87
  投资活动产生的现金流量净额-27,037,575.12-269,735,898.63-131,831,709.77-88,778,022.08
三、筹资活动产生的现金流量:
  吸收投资收到的现金-19,223,553.78--
  取得借款收到的现金-181,000,000181,000,000150,000,000
  收到其他与筹资活动有关的现金-37,298,177.7128,763,009.8128,743,814.18
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-237,521,731.49209,763,009.81178,743,814.18
  偿还债务支付的现金-311,000,000261,000,000180,000,000
  分配股利、利润或偿付利息支付的现金417,499.99351,083,200.15350,904,435.8178,095,818.76
  支付其他与筹资活动有关的现金1,582,136.2733,829,630.829,508,575.2626,617,003.36
  筹资活动现金流出小计1,999,636.26695,912,830.95641,413,011.06384,712,822.12
  筹资活动产生的现金流量净额-1,999,636.26-458,391,099.46-431,650,001.25-205,969,007.94
四、汇率变动对现金及现金等价物的影响907,818.63-1,669,055.28-1,647,447.59-1,624,291.66
五、现金及现金等价物净增加额180,318,006.6923,592,732.319,391,025.699,178,559.9
  加:期初现金及现金等价物余额386,429,915.27362,837,182.96362,837,182.96362,837,182.96
  期末现金及现金等价物余额566,747,921.96386,429,915.27372,228,208.65372,015,742.86
补充资料:
  净利润-695,855,596.25-334,826,054.8
  资产减值准备-15,176,291.68-8,790,633.82
  固定资产和投资性房地产折旧-91,890,630.49-41,930,834.96
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-91,890,630.49-41,930,834.96
  无形资产摊销-11,568,709.56-5,355,829.66
  长期待摊费用摊销-2,593,093.55-1,320,827.91
  处置固定资产、无形资产和其他长期资产的损失--52,536.38--74,796.81
  固定资产报废损失-495,132.67--
  财务费用-6,104,842.08-4,427,696.75
  递延所得税-4,368,487.14-474,376.36
  其中:递延所得税资产减少-4,368,487.14-474,376.36
  存货的减少--47,601,868.52--30,519,985.24
  经营性应收项目的减少--174,849,913.41--74,486,798.66
  经营性应付项目的增加-129,834,838.88-4,586,582.83
  其他-6,598,501.41-4,198,975.22
  现金的期末余额-386,429,915.27-372,015,742.86
  减:现金的期初余额-362,837,182.96-362,837,182.96
  现金及现金等价物的净增加额-23,592,732.31-9,178,559.9
公告日期2026-04-282026-04-222025-10-292025-08-28
审计意见(境内)标准无保留意见
TOP↑